What happens to a drug distributor following a satisfactory inspection by the FDA?

A satisfactory inspection by the FDA means that the drug distributor has met the necessary compliance standards at the time of the inspection. Following such an inspection, the distributor is not completely exempt from future inspections; rather, they remain subject to ongoing oversight. However, they will not be inspected again unless there are indications of a problem, such as a less than satisfactory rating or other cause for concern. This helps maintain regulatory compliance while ensuring that inspections are focused on those facilities that may be at risk of noncompliance.

The other options suggest various exemptions or reporting requirements that do not align with FDA practices following a satisfactory inspection. In reality, FDA maintains the authority to conduct inspections as needed, making the idea of permanent exemption and the requirement for quarterly reporting inaccurate in this context.